BIOMAT Database Logo BIOMAT Database Logo

Delayed elimination of methotrexate by cola beverages in a pediatric acute lymphoblastic leukemia population. 2013

Tiene Bauters, and Tim Lammens, and Pauline Belin, and Yves Benoit, and Hugo Robays, and Barbara de Moerloose

UI MeSH Term Description Entries
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D001628 Beverages Liquids that are suitable for drinking. (From Merriam Webster Collegiate Dictionary, 10th ed) Beverage
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D054198 Precursor Cell Lymphoblastic Leukemia-Lymphoma A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias. Leukemia, Lymphoblastic,Leukemia, Lymphoid, Acute,Lymphoblastic Leukemia,Lymphoblastic Lymphoma,Lymphocytic Leukemia, Acute,Lymphoma, Lymphoblastic,ALL, Childhood,Acute Lymphoid Leukemia,Leukemia, Acute Lymphoblastic,Leukemia, Lymphoblastic, Acute,Leukemia, Lymphoblastic, Acute, L1,Leukemia, Lymphoblastic, Acute, L2,Leukemia, Lymphoblastic, Acute, Philadelphia-Positive,Leukemia, Lymphocytic, Acute,Leukemia, Lymphocytic, Acute, L1,Leukemia, Lymphocytic, Acute, L2,Lymphoblastic Leukemia, Acute,Lymphoblastic Leukemia, Acute, Adult,Lymphoblastic Leukemia, Acute, Childhood,Lymphoblastic Leukemia, Acute, L1,Lymphoblastic Leukemia, Acute, L2,Lymphocytic Leukemia, L1,Lymphocytic Leukemia, L2,Acute Lymphoblastic Leukemia,Acute Lymphocytic Leukemia,Childhood ALL,L1 Lymphocytic Leukemia,L2 Lymphocytic Leukemia,Leukemia, Acute Lymphocytic,Leukemia, Acute Lymphoid,Leukemia, L1 Lymphocytic,Leukemia, L2 Lymphocytic,Lymphoid Leukemia, Acute,Precursor Cell Lymphoblastic Leukemia Lymphoma
D030221 Cola A plant genus of the family STERCULIACEAE. This is the source of the kola nut which contains CAFFEINE and is used in popular beverages. Cola acuminata,Cola nitida,Kola Nut,Kola Nuts,Nut, Kola,Nuts, Kola

Related Publications

Tiene Bauters, and Tim Lammens, and Pauline Belin, and Yves Benoit, and Hugo Robays, and Barbara de Moerloose
Cola beverage and delayed elimination of methotrexate.
November 2010, British journal of clinical pharmacology,
Tiene Bauters, and Tim Lammens, and Pauline Belin, and Yves Benoit, and Hugo Robays, and Barbara de Moerloose
Genetic factors involved in delayed methotrexate elimination in children with acute lymphoblastic leukemia.
May 2021, Pediatric blood & cancer,
Tiene Bauters, and Tim Lammens, and Pauline Belin, and Yves Benoit, and Hugo Robays, and Barbara de Moerloose
Population pharmacokinetics of methotrexate in Mexican pediatric patients with acute lymphoblastic leukemia.
January 2020, Cancer chemotherapy and pharmacology,
Tiene Bauters, and Tim Lammens, and Pauline Belin, and Yves Benoit, and Hugo Robays, and Barbara de Moerloose
Population pharmacokinetic study of delayed methotrexate excretion in children with acute lymphoblastic leukemia
.
August 2019, International journal of clinical pharmacology and therapeutics,
Tiene Bauters, and Tim Lammens, and Pauline Belin, and Yves Benoit, and Hugo Robays, and Barbara de Moerloose
[Clinical application of the simultaneous detection of methotrexate and 7-hydroxymethotrexate in the delayed elimination for pediatric acute lymphoblastic leukemia].
July 2020, Zhonghua yi xue za zhi,
Tiene Bauters, and Tim Lammens, and Pauline Belin, and Yves Benoit, and Hugo Robays, and Barbara de Moerloose
Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia.
July 2017, Pediatric blood & cancer,
Tiene Bauters, and Tim Lammens, and Pauline Belin, and Yves Benoit, and Hugo Robays, and Barbara de Moerloose
Plasma creatinine as predictor of delayed elimination of high-dose methotrexate in childhood acute lymphoblastic leukemia: A Danish population-based study.
June 2019, Pediatric blood & cancer,
Tiene Bauters, and Tim Lammens, and Pauline Belin, and Yves Benoit, and Hugo Robays, and Barbara de Moerloose
Risk factors for delayed elimination of high-dose methotrexate in childhood acute lymphoblastic leukemia and lymphoma.
May 2021, International journal of hematology,
Tiene Bauters, and Tim Lammens, and Pauline Belin, and Yves Benoit, and Hugo Robays, and Barbara de Moerloose
Population Pharmacokinetic Model of Methotrexate in Brazilian Pediatric Patients with Acute Lymphoblastic Leukemia.
July 2023, Pharmaceutical research,
Tiene Bauters, and Tim Lammens, and Pauline Belin, and Yves Benoit, and Hugo Robays, and Barbara de Moerloose
Effects of SLCO1B1 on elimination and toxicities of high-dose methotrexate in pediatric acute lymphoblastic leukemia.
October 2022, Pharmacogenomics,
Copied contents to your clipboard!